Apogee Therapeutics, Inc.

APGE · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $6.2B · 261 employees
53
SEC Filings
$132.69
Close 2026-06-24
261
Employees

Business Summary

Overview We are a clinical stage biotechnology company advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. Our antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of...

Latest Stock Quote

APGE 2026-06-24 $132.69 O:$132.9 H:$133 L:$132.64 Vol:7.7M VWAP:$132.8104
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001974640-26-000002EDGAR96K words
2025-03-032024-12-310000950170-25-030385EDGAR—
2024-03-052023-12-310001558370-24-002406EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-102026-06-300001193125-26-341289EDGAR—
2025-11-102025-09-300001193125-25-273260EDGAR62K words
2025-08-112025-06-300000950170-25-106234EDGAR—
2025-05-122025-03-310000950170-25-068513EDGAR—
2024-11-122024-09-300000950170-24-124559EDGAR—
2024-08-122024-06-300000950170-24-095053EDGAR—
2024-05-132024-03-310001558370-24-007861EDGAR—
2023-11-132023-09-300001558370-23-018692EDGAR—
2023-08-282023-06-300001558370-23-015278EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-100001193125-26-341239EDGAR—
2026-03-250001104659-26-034579EDGAR29K words
2026-03-230001104659-26-032950EDGAR—
2026-03-020001974640-26-000001EDGAR—
2026-01-060001104659-26-001063EDGAR—
2025-11-100001193125-25-273250EDGAR—
2025-10-100001104659-25-098487EDGAR—
2025-08-110000950170-25-106228EDGAR—
2025-07-070001104659-25-065926EDGAR—
2025-06-230000950170-25-088600EDGAR—

53 total filings indexed. 31 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Company Identity

CIK0001974640
TickerAPGE
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://www.apogeetherapeutics.com
Listed2023-07-14

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 86d1d9c2920bb9f8bebddf1150597c5cb0dd6e0cd9c601f65b289e7ceabcd223
parent: 2bde66fcc8c05e43a0a4aa7457c431980c169f071fc3fecea565b251b76cc2e5
content hash: 34bbc56518b9285d4fa3d84c9efa0cc844dba05f4b77624850f7ee1ac310a0f1
signed: 2026-08-10T19:00:51.704Z
sources: 12 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up APGE using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on APGE, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/APGE (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.